NCT02734329Unknown不适用
Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- the change in glomerular filtration rate (GFR) of the affected kidney
研究概览
简要总结
Zero ischemia laparoscopic radio frequency ablation assisted tumor enucleation has been proved to enable tumor excision with relatively better renal function preservation comparing with conventional laparoscopic partial nephrectomy for T1a renal cell carcinoma (RCC) in a randomized clinical trial in single center. The investigators want to explore this technique to T1 RCC patients in randomized clinical trial in multiple centers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 15 Years 至 80 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients with sporadic, unilateral, newly diagnosed T1 presumed renal cell carcinoma
- •patients scheduled for laparoscopic nephron sparing surgery
- •patients agreeable to participate in this long-term follow-up study
排除标准
- •patients' aged >80 years
- •patients with other renal diseases,(including kidney stone, glomerular nephritis, etc.) which might affect the renal function of the operative kidney
- •patients not able to tolerate the laparoscopic procedure
- •patients with previous renal surgery or history of any inflammatory conditions of the operative kidney
- •patients with the renal tumor involving urinary collecting system
结局指标
主要结局
the change in glomerular filtration rate (GFR) of the affected kidney
时间窗: Baseline and 30 months
changes of estimated GFR (eGFR)
时间窗: Baseline and 30 months
次要结局
- estimated blood loss(during surgery)
- postoperative complications(postoperative，up to 30 days)
- progression-free survival rate(through study completion, an average of 3 years)
- rates of positive surgical margin(postoperative，up to 2 weeks after surgery)
- operative time(During surgery)
- the rate of local recurrence(through study completion, an average of 3 years)
- Hospital stay time(The time from the surgery day to patient discharge, up to 2 weeks)
研究者
Yiran Huang
Director of Urology
RenJi Hospital
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 StageKidney NeoplasmsNCT06715878RenJi Hospital80
Unknown
不适用
Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a StageZero IschemiaRenal Cell CarcinomaNCT01838720RenJi Hospital90
Unknown
不适用
Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a StageRenal Cell CarcinomaNCT02924597RenJi Hospital100
招募中
不适用
Endoscopic radiofrequency ablation combined with metal stent placement for malignant biliary obstruction in patients with surgically altered anatomyJPRN-UMIN000033957Aichi Medical University15
已完成
不适用
minimal invasive treatment with radiofrequency ablation of breast carcinoma in elderly patients(>70 years) who are not or less fit for surgeryNL-OMON31718Jeroen Bosch Ziekenhuis10